Johnson & Johnson

NYSE: JNJ · Real-Time Price · USD
176.93
0.68 (0.39%)
At close: Aug 19, 2025, 9:31 AM

Johnson & Johnson Cash Flow Statement

Financials in USD. Fiscal year is February - January.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 29, 2024 Dec 31, 2023 Jan 1, 2023 Jan 2, 2022
Net Income
14.07B 13.33B 17.94B 20.88B
Depreciation & Amortization
7.34B 7.49B 6.97B 7.39B
Stock-Based Compensation
1.18B 1.16B 1.14B 1.14B
Other Working Capital
1.75B 2.11B -1.29B -3.02B
Other Non-Cash Items
2.03B 2.5B 819M 324M
Deferred Income Tax
-2.18B -4.19B -1.66B -2.08B
Change in Working Capital
1.84B 2.51B -4.01B -4.24B
Operating Cash Flow
24.27B 22.79B 21.19B 23.41B
Capital Expenditures
-4.42B -4.54B -4.01B -3.65B
Cash Acquisitions
-15.15B n/a -17.65B -60M
Purchase of Investments
-1.73B -10.91B -32.38B -30.39B
Sales Maturities Of Investments
2.46B 19.39B 41.61B 25.01B
Other Investing Acitivies
235M -3.06B 65M 417M
Investing Cash Flow
-18.6B 878M -12.37B -8.68B
Debt Repayment
10.05B -2.73B 7.45B -990M
Common Stock Repurchased
-2.43B -5.05B -6.04B -3.46B
Dividend Paid
-11.82B -11.77B -11.68B -11.03B
Other Financial Acitivies
1.07B -508M 1.39B 1.43B
Financial Cash Flow
-3.13B -15.82B -8.87B -14.05B
Net Cash Flow
2.25B 7.73B -360M 502M
Free Cash Flow
19.84B 18.25B 17.18B 19.76B